Drugs
-
First-Time Generic Drug Approvals - September 2012
| Generic Drug Name | Generic Manufacturer | Brand Name | Approval Date | |
|---|---|---|---|---|
| 1 | VALSARTAN AND HYDROCHLOROTHIAZIDE TABLETS, 80 MG/12.5 MG, 160 MG/12.5 MG, 160 MG/25 MG, 320 MG/12.5 MG AND 320 MG/25 MG | MYLAN PHARMACEUTICALS, INC. | DIOVAN HCT TABLETS | 9/21/2012 |
| 2 | APREPITANT CAPSULES, 40 MG, 80 MG AND 125 MG | SANDOZ INC. | EMEND CAPSULES | 9/24/2012 |
| 3 | AMLODIPINE, VALSARTAN AND HYDROCHLOROTHIAZIDE TABLETS, 5 MG/160 MG/12.5 MG, 10 MG/160 MG/12.5 MG, 5 MG/160 MG/25 MG, 10 MG/160 MG/25 MG AND 10 MG/320 MG/25 MG | TEVA PHARMACEUTICALS, USA | EXFORGE HCT TABLETS | 9/25/2012 |
| 4 | QUININE SULFATE CAPSULES USP, 324 MG | TEVA PHARMACEUTICALS, USA | QUALAQUIN CAPSULES | 9/28/2012 |
| 5 | PROGESTERONE CAPSULES, 100 MG AND 200 MG | SOFGEN PHARMACEUTICALS, LLC | PROMETRIUM CAPSULES | 9/28/2012 |
-
-







